Pharmaceutical Processing

The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News

Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Actavis and Medicines360 Announce Partnership to Advance Women's Access to Affordable IUDs

June 11, 2013 8:06 am | News | Comments

Medicines360, a non-profit pharmaceutical company, and Actavis, Inc., a global specialty pharmaceutical company, today announced a historic partnership to support Medicines360's mission to reduce cost as a barrier to accessing women's birth control.  The Medicines360 and Actavis partnership will make the IUD available in the U.S. commercially and at a very low price in U.S. public sector clinics.

TOPICS:

Ex-Bristol-Myers Exec Admits Insider Trading in NJ

June 10, 2013 4:43 pm | by The Associated Press | News | Comments

Federal prosecutors in New Jersey say a former executive for biopharmaceuticals company Bristol-Myers Squibb has admitted using his high-level position and access to nonpublic information to make about $310,000 from insider trades. Robert Ramnarine pleaded guilty Monday to securities fraud. The...

TOPICS:

Vision350 Flat Fascia Models

June 10, 2013 3:16 pm | Product Releases | Comments

With the flat fascia Vision350™ P66/IP65/NEMA4X rating, these units are ideal wherever spray/wipe down applications apply. The PLC + HMI advantage gives users the opportunity to operate on a minimum of budget, programming time and wiring.

Advertisement

90° Peel Fixture

June 10, 2013 3:01 pm | Product Releases | Comments

The 90° peel fixture for use with the CT3 tester is designed to measure the adhesion force between two materials. The fixture maintains a 90° angle as the tape is pulled away from the substrate. 

Apricus impotence drug approved in 10 countries

June 10, 2013 12:45 pm | by The Associated Press | News | Comments

Apricus Biosciences Inc. said Monday that its impotence drug Vitaros has been approved in 10 European countries. The company said Vitaros is now approved in the Netherlands, Germany, France, Italy, and the U.K., among other countries, for the treatment of erectile dysfunction. Apricus sought...

TOPICS:

First FDA Approved Weight Loss Drug in 10 Years on the Market

June 10, 2013 8:45 am | Videos | Comments

Belviq will be available to U.S. patients this next week, nearly a year after the drug was officially approved by federal regulators. The FDA approved Belviq last June for adults who are obese or who are overweight and have at least one serious medical condition, such as diabetes or high cholesterol.

TOPICS:

Africa Hopes to Speed up Medicine Approval Systems

June 10, 2013 8:37 am | by JASON STRAZIUSO,Associated Press | News | Comments

Bringing a new medicine to market in Africa requires 54 separate applications to each country on the continent, a time-intensive process that could be costing lives. African leaders are now trying to move toward a regional and eventually continentwide approach to speed the process.

Oregon Senate Passes Bill on Vaccination Education

June 10, 2013 8:24 am | by LAUREN GAMBINO,Associated Press | News | Comments

A bill that is intended to persuade more Oregon parents to take their kids to doctors for shots and get over their mistrust of conventional medicine has taken a big step in the Legislature with passage by the state Senate. Oregon has the nation's highest rate of parents refusing vaccinations for their kindergartners for nonmedical reasons.

TOPICS:
Advertisement

Cumberland Pharmaceuticals Reports FDA Approval For Updated Acetadote Labeling

June 10, 2013 8:21 am | News | Comments

Cumberland Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Acetadote (acetylcysteine) Injection. The new labeling revises the product's indication and offers new dosing guidance for specific patient populations.

TOPICS:

FDA Finds Fungus in Drugs from Tennessee Pharmacy

June 10, 2013 8:17 am | by MATTHEW PERRONE,AP Health Writer | News | Comments

The Food and Drug Administration said in an online posting Friday that it identified the growths in two unopened vials of a steroid injection distributed by the Main Street Family Pharmacy, a compounding pharmacy in Newbern, Tenn. The agency said it is working with the Centers for Disease Control and Prevention to identify the exact species of fungus and bacteria.

TOPICS:

Ex-Worker Seeks Home for Miles Memorabilia

June 10, 2013 8:14 am | by TIM VANDENACK,The Elkhart Truth | News | Comments

Arden Stickel is worried. He's getting on in years and won't be around forever, so he's got to figure out what to do with all his Miles Laboratories bottles and pills. And promotional Frisbees. And company newsletters. And Speedy dolls, Speedy being the Alka-Seltzer pitchman of yesteryear.

Elan Rejects Royalty Bid, To Evaluate Other Offers

June 10, 2013 8:10 am | by The Associated Press | News | Comments

The board of directors of the Irish drugmaker Elan Corp. PLC on Monday rejected an increased offer from Royalty Pharma and says it has received unsolicited interest from other parties it didn't name. Royalty's latest offer last week was for $13 per share plus up to $2.50 per share in payments based on performance milestones. That offer totaled about $7.76 billion not counting the milestone payments.

TOPICS:

AstraZeneca to Acquire Pearl Therapeutics to Strengthen Respiratory Portfolio

June 10, 2013 8:07 am | News | Comments

AstraZeneca announced today that it has entered into a definitive agreement to acquire Pearl Therapeutics, a privately held company based in Redwood City, California, focused on the development of inhaled small-molecule therapeutics for respiratory disease.

TOPICS:

Weight Loss Drug Belviq Gets Overdue US Launch

June 7, 2013 11:39 am | by MATTHEW PERRONE - AP Health Writer - Associated Press | News | Comments

Arena Pharmaceuticals says its weight loss drug Belviq will be available to U.S. patients beginning next week, nearly a year after the drug was officially approved by federal regulators. The Food and Drug Administration approved Belviq last June for adults who are obese or who are overweight and...

TOPICS:

Flat Surface pH/ORP Electrode

June 7, 2013 11:33 am | Product Releases | Comments

The S8000 series modular electrode platform has been expanded with the addition of the S8075CD in-line pH electrode and S8075CD-ORP in-line oxidation reduction potential (ORP) electrode.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading